The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
 
Virginia Calvo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
 
Manuel Domine
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche
 
Ivana Sullivan
No Relationships to Disclose
 
Jose-Luis Gonzalez-Larriba
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology
Speakers' Bureau - MSD Oncology
Research Funding - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Ignyta; Janssen-Cilag; Mirati Therapeutics; Novartis; OncoMed; Pfizer; PharmaMar; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Takeda
 
Ana Laura Ortega
No Relationships to Disclose
 
Reyes Bernabé
No Relationships to Disclose
 
Maria Angeles Sala
No Relationships to Disclose
 
Begona Campos
No Relationships to Disclose
 
Javier De Castro
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Merck Sharp and Dohme; Pfizer; Pierre Fabre; Roche; Takeda; Tesaro; Teva
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca Spain; Merck Sharp & Dohme; Roche
 
Paloma Martín-Martorell
No Relationships to Disclose
 
Joaquim Bosch-Barrera
No Relationships to Disclose
 
Xabier Mielgo
No Relationships to Disclose
 
Laia Vilà
Honoraria - Bristol-Myers Squibb/Pfizer; MSD; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - MSD
 
Joaquin Casal
No Relationships to Disclose
 
Silver Ros
No Relationships to Disclose
 
Maite Martinez Aguillo
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
 
Airam Padilla
No Relationships to Disclose
 
Sergio Sandiego
No Relationships to Disclose
 
Jonathan Aires Machado
No Relationships to Disclose
 
Mariano Provencio-Pulla
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Speakers' Bureau - AstraZeneca; BMS; MSD; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; ROCHE